Randomized, controlled trial of Platinum-Cetuximab combined either with Docetaxel (TPEx) or with 5FU (Extreme) in patients with recurrent/metastatic squamous cell cancer of the head and neck (TPExtreme)

Docetaxel, 5-Fluorouracil (5-FU)

Status: Rekrutierung beendet

Klinische Settings

Beteiligte

Identifier

Links

Kontakt